Hepatitis C infects nearly 4 million Americans. Most have chronic hepatitis C (CHC), which progresses to cirrhosis in about 20% of patients. Interferon treatment leads to transient responses in about 40% of patients and apparent eradication of infection in 7% to 40% of patients. In this report, we d
Impaired health-related quality of life in chronic hepatitis C: The how, but not the why
β Scribed by Raymond S. Koff
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 30 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
During the past decade, patient-based health outcomes research has become a growth industry. Its data are being merged with clinical and economic databases to inform health care decision-making. Supported by a variety of health care organizations, accrediting bodies, employers, health policy strategists, and an expanding coterie of investigators, outcomes research seeks to assess the health of populations and the value of health care interventions as reflected in measurable changes in outcomes. With increasing emphasis on the patient as the focal point of health care, preservation of functioning and well-being is viewed as the principal goal of medical care and, of course, is best evaluated by the patient. As a consequence, measurement of patient-based assessment of health-related quality of life (HRQOL) is now an important focus of outcomes research.
However, the term and concept of ''quality of life'' has been problematic. 1 Quality of life is generally defined as an individual' s overall satisfaction with life and general sense of well-being and includes elements regarding health, personal accomplishments and resources, life situation, spirituality, level of activity, and social support. 2 HRQOL may be more narrowly and specifically defined. It focuses on self-perceived health and well-being domains. These include assessments of physical function, somatic sensation, psychological status, social interactions, functional capacity, and sense of wellbeing as influenced by health status. Each of these is subjective, based entirely on the perception of the individual, and usually self-reported. No objective functional testing or assessment is included. HRQOL in patients may also be defined by the nature and intensity of symptoms of the responsible disease and those attributable to its treatment. From a patient' s perspective, important outcomes of health interventions include the elimination or reduction of symptoms, if present, improved health-related quality of life, and restoration of normal life expectancy. Although its proponents would suggest that HRQOL is the outcome patients care most about, one wonders-perhaps as one ageswhether restoration of life expectancy might be an even higher priority, at least for some.
Abbreviations: HRQOL, health-related quality of life; SF-36, short form-36.
π SIMILAR VOLUMES
This study assessed the effect of chronic hepatitis C virus (HCV) infection on the healthrelated quality of life (HRQOL) of injecting drug users, comparing the HRQOL of injecting drug users with and without chronic HCV infection. The study included 199 injecting drug users of more than 18 years of a
Previous Western studies showed a consistent and marked reduction in health-related quality of life (HRQOL) in patients chronically infected with hepatitis C virus (HCV). However, these studies were conducted on patients whose knowledge of their serological status may have affected their HRQOL. This
## Abstract The pathogenesis of hepatitis C virusβinduced chronic liver disease is still poorly understood. Previous studies revealed enhanced hepatic expression of the Th1 prototype cytokine IFNβΞ³ in individuals with chronic hepatitis C. In accordance with several animal models of experimentally i